SCHEMBL9759587

SCHEMBL9759587

NC(=O)NNc1cccc2c1CCCC2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.52
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
SIGMAR1 Q99720 2/20 0.51
GRIN2D O15399 1/20 0.51
GRIN3B O60391 1/20 0.51
GRIN1 Q05586 1/20 0.51
GRIN2A Q12879 1/20 0.51
GRIN2B Q13224 1/20 0.51
GRIN2C Q14957 1/20 0.51
GRIN3A Q8TCU5 1/20 0.51
LMNA P02545 1/20 0.51
THRA P10827 1/20 0.51
THRB P10828 1/20 0.51
TSHR P16473 2/20 0.51
L3MBTL1 Q9Y468 2/20 0.50
KDM4E B2RXH2 2/20 0.50
RXRA P19793 1/20 0.48
RXRB P28702 1/20 0.48
RXRG P48443 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2357753 0.83 ALDH1A1 (0.63) ALDH1A1MEN1KMT2ASIGMAR1GRIN2D
SCHEMBL7905159 0.80 BCL2L1 (0.54) ALDH1A1MEN1KMT2ASIGMAR1GRIN2D
SCHEMBL6627142 0.75 ALDH1A1 (0.65) ALDH1A1MEN1KMT2ASIGMAR1GRIN2D
SCHEMBL6627140 0.75 ALDH1A1 (0.65) ALDH1A1MEN1KMT2ASIGMAR1GRIN2D
SCHEMBL17894510 0.73 SIGMAR1 (0.61) ALDH1A1MEN1KMT2ASIGMAR1GRIN2D
SCHEMBL4512663 0.73 SIGMAR1 (0.61) ALDH1A1MEN1KMT2ASIGMAR1GRIN2D
SCHEMBL1638724 0.73 ALDH1A1 (0.72) ALDH1A1MEN1KMT2ASIGMAR1GRIN2D
SCHEMBL5418295 0.73 ALDH1A1 (0.63) ALDH1A1MEN1KMT2ASIGMAR1GRIN2D
SCHEMBL7262779 0.73 SIGMAR1 (0.53) ALDH1A1MEN1KMT2ASIGMAR1GRIN2D
SCHEMBL4573751 0.73 RXRA (0.57) ALDH1A1MEN1KMT2ASIGMAR1GRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0272534-A2 8-substituted 2-aminotetralins BAYER AG (DE) 1988-06-29 EP claimed
US-5047422-A Treating A Disorder Of The Central Nervous System, Cardiovascular System Or Intestinal Tract BAYER AKTIENGESELLSCHAFT (DE) 1991-09-10 US disclosed
US-4968679-A DISORDERS OF CENTRAL NERVOUS SYSTEM, CARDIOVASCULAR SYSTEM OR INTESTINAL TRACT BAYER AKTIENGESELLSCHAFT (DE) 1990-11-06 US disclosed
US-4873262-A TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, CARDIIOVASCULAR SYSTEM OR INTESTINAL TRACT BAYER AKTIENGESELLSCHAFT (DE) 1989-10-10 US disclosed
EP-0272534-A2 8-substituted 2-aminotetralins BAYER AG (DE) 1988-06-29 EP disclosed